Editorial
Published on 17 Nov 2023
Editorial: Evolution in respiratory pharmacology
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1329811
- 1,035 views
Type at least 3 characters
580 articles
Articles
Correction
Published on 13 Nov 2023
Corrigendum: Efficacy of a paper-based interleukin-6 test strip combined with a spectrum-based optical reader for sequential monitoring and early recognition of respiratory failure in elderly pneumonia-a pilot study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1250358
- 555 views
Review
Published on 01 Nov 2023
Application of radiomics in diagnosis and treatment of lung cancer
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1295511
- 4,048 views
- 11 citations
Original Research
Published on 18 Oct 2023
Integration of metabolomics and network pharmacology to reveal the protective mechanism underlying Qibai Pingfei capsule on chronic obstructive pulmonary disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1258138
- 3,464 views
Original Research
Published on 12 Oct 2023
Prednisone-hydrogen sulfide releasing hybrid shows improved therapeutic profile in asthma
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1266934
- 2,308 views
- 4 citations
Original Research
Published on 11 Oct 2023
Hypoxia releases S-nitrosocysteine from carotid body glomus cells—relevance to expression of the hypoxic ventilatory response
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1250154
- 1,597 views
- 1 citation
Original Research
Published on 03 Oct 2023
Exposure-response analyses of efzofitimod in patients with pulmonary sarcoidosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1258236
- 2,541 views
- 2 citations
Original Research
Published on 21 Sep 2023
Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1245885
- 2,298 views
- 3 citations
Original Research
Published on 14 Sep 2023
Exploration of the mechanism of aloin ameliorates of combined allergic rhinitis and asthma syndrome based on network pharmacology and experimental validation
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1218030
- 2,417 views
- 6 citations
Original Research
Published on 05 Sep 2023
Using extracellular matrix derived from sugen-chronic hypoxia lung tissue to study pulmonary arterial hypertension
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1192798
- 1,974 views
Original Research
Published on 01 Sep 2023
Use of polymyxin B with different administration methods in the critically ill patients with ventilation associated pneumonia: a single-center experience
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1222044
- 2,373 views
- 4 citations
Original Research
Published on 24 Aug 2023
Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1236469
- 2,721 views
- 2 citations
Original Research
Published on 23 Aug 2023
Obesity exacerbates influenza-induced respiratory disease via the arachidonic acid-p38 MAPK pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1248873
- 2,151 views
- 3 citations
Original Research
Published on 16 Aug 2023
A 20:1 synergetic mixture of cafedrine/theodrenaline accelerates particle transport velocity in murine tracheal epithelium via IP3 receptor-associated calcium release
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1155930
- 1,296 views
- 1 citation
Original Research
Published on 16 Aug 2023
Prognostic value of oxygen inhalation therapy for simple nocturnal hypoxemia in COPD: a meta-analysis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1123945
- 1,542 views
Original Research
Published on 16 Aug 2023
Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1209063
- 2,169 views
- 3 citations